Home/Amygdala Neurosciences/Ivan Diamond, MD, PhD

ID

Ivan Diamond, MD, PhD

Chief Scientific Officer & Founder

Amygdala Neurosciences

Therapeutic Areas

Substance Use Disorders Psychiatry

Amygdala Neurosciences Pipeline

Drug	Indication	Phase
ANS-858	Alcohol Use Disorder (AUD)	Preclinical
Platform Expansion	Smoking Cessation	Research

Leadership Team at Amygdala Neurosciences

Brent Blackburn, PhD

Chief Executive Officer & Founder

Lou Lange, MD, PhD

Executive Chairman & Founder

Mack Mitchell, MD

Medical Advisor

Adrienne MacMillan

Chief Financial Officer & Founder

View full Amygdala Neurosciences profile